YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (HK:1558) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is in the process of a proposed pre-conditional privatization by Sunshine Lake Pharma Co., Ltd., with numerous pre-conditions yet to be met for the merger to become effective. Shareholders and investors are cautioned to consult professional advisers due to the uncertainties involved in the merger’s completion. As of the latest update, the company is actively preparing necessary filings but has not yet satisfied any of the pre-conditions for the merger.
For further insights into HK:1558 stock, check out TipRanks’ Stock Analysis page.